siltuximab 100 MG Injection

RxCUI
1658132
RxNorm name
siltuximab 100 MG Injection
Display name
siltuximab 100 MG Injection
Full name
siltuximab 100 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125496Sylvantsiltuximab351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SylvantSILTUXIMABRecordati Rare Diseases, Inc.8d663642-f52e-49c0-a023-2da083fdfc0b2024-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1658132

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8d663642-f52e-49c0-a023-2da083fdfc0bsiltuximab 100 MG Injection [PSN] · siltuximab 100 MG Injection [SCD]27These highlights do not include all the information needed to use SYLVANT ® safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 201420240827